View Older Stories

Jul 31, 2026 05:04AM DexCom (DXCM) PT Raised to $93 at Truist Securities

Jul 31, 2026 05:03AM DexCom (DXCM) PT Raised to $95 at Stifel

Jul 30, 2026 04:12PM DexCom (DXCM) Tops Q2 EPS by 9c ; Offers Guidance

Jul 28, 2026 07:51AM UBS Starts DexCom (DXCM) at Buy

Jul 22, 2026 05:16PM Dexcom selected as first participant in FDA's TEMPO pilot

Jul 16, 2026 11:16AM DexCom (DXCM) PT Raised to $87 at Truist Securities

Jul 13, 2026 04:46PM Health Canada authorizes Dexcom G7 15 Day CGM for Canadian adults

Jul 12, 2026 10:00AM U.S. MedTech stocks: Q2 earnings preview

Jun 23, 2026 09:01AM Dexcom wins FDA pediatric clearance for Stelo glucose sensor

Jun 23, 2026 07:49AM Deutsche Bank Starts DexCom (DXCM) at Buy

Jun 23, 2026 06:49AM DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised

Jun 12, 2026 04:14PM FDA clears first over-the-counter glucose monitor for children

Jun 12, 2026 03:43PM FDA clears Dexcom's over-the-counter glucose monitor for children

Jun 11, 2026 06:23AM Pharmsource says it was unaware Dexcom sensors were stolen

Jun 10, 2026 08:30AM DexCom (DXCM) PT Raised to $95 at TD Cowen as 'CONNECT and MACE Data Impress at ADA'

Jun 9, 2026 06:42AM DexCom (DXCM) PT Raised to $85 at Mizuho

Jun 6, 2026 03:18PM Dexcom study shows glucose monitor reduces A1C in type 2 diabetes patients

Jun 4, 2026 09:05AM Dexcom to present diabetes study results and launch updated glucose app

May 26, 2026 09:30AM Dexcom reports theft of scrapped glucose sensors sold to customers

May 18, 2026 07:17AM DexCom (DXCM) PT Lowered to $82 at Canaccord

May 18, 2026 05:44AM DexCom (DXCM) PT Lowered to $80 at BofA Securities

May 15, 2026 08:55AM Piper Sandler on DexCom (DXCM): 'Well Done Investor Meeting Provides Excellent Stock Setup'

May 15, 2026 08:31AM Truist on DexCom (DXCM): 'Catalyst Rich 27-28 Ahead'

May 15, 2026 07:54AM DexCom (DXCM) Reiterated at Buy by Benchmark After Investor Event

May 14, 2026 04:31PM After-hours movers: AMAT, FIG, DXCM, DLO, STNE, PZZA

May 14, 2026 04:03PM Dexcom adds two directors, expands board committee following Elliott talks

May 12, 2026 08:51AM TD Cowen Reiterates Buy Rating on DexCom (DXCM)

May 12, 2026 05:48AM Benchmark Starts DexCom (DXCM) at Buy

May 1, 2026 06:49AM DexCom (DXCM) PT Raised to $100 at Canaccord

May 1, 2026 05:32AM DexCom (DXCM) PT Lowered to $77 at Bernstein SocGen Group

May 1, 2026 05:12AM DexCom (DXCM) PT Lowered to $75 at Mizuho

Apr 30, 2026 04:03PM DexCom (DXCM) Tops Q1 EPS by 9c; offers guidance

Apr 2, 2026 08:48AM TD Cowen Highlights a 'Compelling 2026-2028 Margin Story' at DexCom (DXCM)

Mar 24, 2026 06:13AM Evercore ISI Upgrades DexCom (DXCM) to Outperform, 'Turning the page to T2 NIT expansion'

Mar 9, 2026 08:18AM Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'

Feb 13, 2026 08:42AM DexCom (DXCM) PT Lowered to $95 at Canaccord Genuity

Feb 13, 2026 02:43AM Stifel Reiterates Buy Rating on DexCom (DXCM)

Feb 12, 2026 04:05PM DexCom (DXCM) Tops Q4 EPS by 3c ; Offers Guidance

Feb 5, 2026 08:36AM Piper Sandler on DexCom (DXCM): 'Encouraged About the Stock Setup Over the Long-Term'

Jan 12, 2026 10:45AM Jefferies on DexCom (DXCM): 'We think the '26 guide is conservative, leaving room for upside in stock'

Jan 12, 2026 09:34AM Barclays Downgrades Insulet Corporation (PODD) to Underweight

Jan 12, 2026 09:34AM Barclays Downgrades DexCom (DXCM) to Underweight

Jan 12, 2026 09:04AM Morgan Stanley Reiterates Overweight Rating on DexCom (DXCM), 'Prelim Results Likely Clear the Bar'

Jan 12, 2026 09:01AM Citi Opens 90-Day Upside Catalyst Watch on DexCom (DXCM)

Jan 12, 2026 07:31AM Dexcom reports Q4 revenue of $1.26 billion, provides 2026 outlook

Jan 9, 2026 07:33AM Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'

Jan 7, 2026 10:43AM Goldman: 'Top Call Buying Opportunities for 2026'

Jan 5, 2026 11:00PM BofA’s six MedTech picks for 2026 on strong earnings growth

Dec 18, 2025 11:51AM Raymond James Reiterates Strong Buy Rating on Jabil (JBL)

Dec 16, 2025 06:19AM DexCom (DXCM) PT Raised to $92 at Leerink Partners

View Older Stories